rxstat › Shortages › Hydrochlorothiazide Pindolol

Hydrochlorothiazide Pindolol (Viskazide) shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Hydrochlorothiazide Pindolol is in a widespread shortage in Canada. 2 of 2 reported products are affected. Manufacturers have not committed to a recovery date.

A combination of a diuretic and a beta blocker used to lower blood pressure.

Products affected
2 / 2
In shortage since
May 1, 2025
Reports on file
4
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
When every manufacturer is affected, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
VISKAZIDE
25MG 10MG · TABLET · XEDITON PHARMACEUTICALS INC
DIN 00568627 · since May 1, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
VISKAZIDE
50MG 10MG · TABLET · XEDITON PHARMACEUTICALS INC
DIN 00568635 · since May 1, 2025, no end estimate · Disruption of the manufacture of the drug.
Resolved
VISKAZIDE
50MG 10MG · TABLET · XEDITON PHARMACEUTICALS INC
DIN 00568635 · ended Apr 13, 2022 · Disruption of the manufacture of the drug.
Resolved
VISKAZIDE
25MG 10MG · TABLET · XEDITON PHARMACEUTICALS INC
DIN 00568627 · ended Apr 13, 2022 · Disruption of the manufacture of the drug.

What's happening

Hydrochlorothiazide Pindolol is currently affected by 2 active shortage reports filed with Health Canada by XEDITON PHARMACEUTICALS INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Hydrochlorothiazide Pindolol is classified under “BETA BLOCKING AGENTS AND OTHER DIURETICS” (ATC C07CA).

Recent changes

Common questions

What is Hydrochlorothiazide Pindolol used for?

A combination of a diuretic and a beta blocker used to lower blood pressure.

When will Hydrochlorothiazide Pindolol be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Hydrochlorothiazide Pindolol in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (beta blocking agents and other diuretics)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Atenolol Chlorthalidone (Tenoretic) Partial shortage 1 of 5 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.